FINWIRES · TerminalLIVE
FINWIRES

$AFL

8 stories mentioning AFLUpdated 27d ago

Every FINWIRES story that references AFL, newest first.

Insider Trading

Aflac Insider Sold Shares Worth $648,897, According to a Recent SEC Filing

Steven Kent Beaver, Executive Vice President, CFO, Aflac Japan, on May 22, 2026, sold 5,508 shares in Aflac (AFL) for $648,897. Following the Form 4 filing with the SEC, Beaver has control over a total of 40,537 common shares of the company, with 40,537 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/4977/000000497726000094/xslF345X05/wk-form4_1779914490.xml

$AFL
Insider Trading

Aflac Insider Sold Shares Worth $268,065, According to a Recent SEC Filing

Arthur Reginald Collins, Director, on May 14, 2026, sold 2,300 shares in Aflac (AFL) for $268,065. Following the Form 4 filing with the SEC, Collins has control over a total of 6,186 common shares of the company, with 6,186 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/4977/000000497726000089/xslF345X05/wk-form4_1778879054.xml

$AFL
Insider Trading

Aflac Insider Sold Shares Worth $737,308, According to a Recent SEC Filing

Charles D Lake II, Chairman & Representative Director, Aflac Life Insurance Japan, on May 05, 2026, sold 6,500 shares in Aflac (AFL) for $737,308. Following the Form 4 filing with the SEC, Lake has control over a total of 52,064 common shares of the company, with 50,737 shares held directly and 1,327 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/4977/000000497726000082/xslF345X05/wk-form4_1778184666.xml

$AFL
Wire

JPMorgan Trims Aflac Price Target to $108 From $109, Maintains Neutral Rating

Aflac (AFL) has an average rating of Hold and mean price target of $112.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $113.87, Change: $+0.99, Percent Change: +0.88%

$AFL
Wire

Jefferies Adjusts Price Target on Aflac to $100 From $97, Maintains Hold Rating

Aflac (AFL) has an average rating of hold and mean price target of $112.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $112.25, Change: $-0.66, Percent Change: -0.59%

$AFL
Wire

Evercore ISI Adjusts Price Target on Aflac to $109 From $112

Aflac (AFL) has an average rating of hold and mean price target of $112.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $112.67, Change: $-3.54, Percent Change: -3.05%

$AFL
Wire

Barclays Adjusts Price Target on Aflac to $99 From $101

Aflac (AFL) has an average rating of hold and mean price target of $112.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $112.67, Change: $-3.54, Percent Change: -3.05%

$AFL
Research

Research Alert: Strength In Japan Propelled Aflac's Q1 Results

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:AFL reported Q1 2026 adjusted EPS of $1.75 versus $1.66 (+5.4%), topping our $1.58 estimate but missing the $1.80 consensus view, with currency headwinds creating a $0.02 negative impact. Net EPS surged to $1.98 from $0.05 (+3,860%) due to a significant swing in investment performance, with net gains of $49M versus $963M in losses. We view the strong underlying insurance operations as encouraging despite persistent Japanese yen weakness affecting results. Management is expected to update its 2026 outlook and sales forecast on tomorrow's conference call. Japan showed particular strength with new annualized premium sales surging 25.5% to 17.7B ($113M), due to successful product launches including Anshin Palette medical insurance and Miraito cancer insurance. U.S. sales growth of 2.9% to $318M primarily reflected group products, though we expect continued distribution challenges given the company's dependence on independent agents in an increasingly digital marketplace.

$AFL

Track with the FINWIRES app suite